Abiopharma

Clinical trial NCT05417594 updates: 1. completion date: 2027-11-01 → 2028-02-07 2. primary completion date: 2027-11-01 → 2028-02-07

Clinical trial NCT07226817: enrollment: 140 → 240 participants.

Clinical trial NCT07504601: start date: 2026-08-16 → 2026-08-17.

Clinical trial NCT07324629 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-03-13

Clinical trial NCT07424144 updates: 1. status: ENROLLING_BY_INVITATION → ACTIVE_NOT_RECRUITING 2. completion date: 2028-12-12 → 2027-02-17 3. primary completion date: 2028-12-12 → 2027-02-17 4. enrollment: 380 → 59 participants 5. enrollment type: ESTIMATED → ACTUAL

General Announcement: Receipt of Letter of Financial Support

Extra Space Storage CEO Joe Margolis Named One of Glassdoors Best CEOs of 2026

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Directors Interest - Tan Wei Yang, Melvin

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

Elucent Medical Selects Knowles Corporation to Manufacture Advanced Surgical Guidance Device